Home › Therapeutic areas › Respiratory
Respiratory (12 companies · 7 conditions)
Conditions
Companies
| Ticker | Company | Therapeutic areas | In Respiratory | Lead stage | Programs |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | DermatologyRespiratory | 1 | Phase 2 | 7 |
| AKBA | Akebia Therapeutics, Inc. | HematologyOphthalmologyRenalRespiratory Rare | 1 | Approved | 14 |
| APGE | Apogee Therapeutics, Inc. | DermatologyRespiratory | 4 | Phase 2 | 8 |
| BEAM | Beam Therapeutics Inc. | HematologyMetabolicRespiratory Rare | 1 | Phase 1 | 8 |
| CLDX | Celldex Therapeutics, Inc. | DermatologyGI/HepatologyImmunologyRespiratory | 1 | Phase 3 | 7 |
| IXHL | Incannex Healthcare Inc. | ImmunologyNeurologyRespiratory | 1 | Phase 2 | 3 |
| KYMR | Kymera Therapeutics, Inc. | DermatologyRespiratory | 1 | Phase 2 | 5 |
| OMER | OMEROS CORP | HematologyNeurologyOncologyRespiratory Rare | 1 | NDA Submitted | 7 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | CardiovascularDermatologyNeurologyRespiratory Rare | 1 | Phase 3 | 10 |
| GPCR | Structure Therapeutics Inc. | MetabolicRespiratory Rare | 1 | Phase 2 | 5 |
| VTVT | vTv Therapeutics Inc. | MetabolicRespiratory Rare | 1 | Phase 3 | 8 |
| WVE | Wave Life Sciences Ltd. | MetabolicNeurologyRespiratory Rare | 1 | Phase 2 | 5 |
No companies match.